Assessment of 6-sulfatoxymelatonin rhythms and melatonin response to light in disease states: Lessons from cirrhosis

Chronobiology International

Volumn 32, Issue 2, 2015, Pages 187-194

  Montagnese, Sara ^a   Middleton, Benita ^b   Corrias, Michela ^a   Mani, Ali Reza ^c   Skene, Debra J ^b   Morgan, Marsha Y ^d  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c TARBIAT MODARES UNIVERSITY   (Iran)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

6 sulphatoxymelatonin; Cirrhosis; Light suppression

Indexed keywords

6-SULFATOXYMELATONIN; MELATONIN;

ADULT; AGED; ANALOGS AND DERIVATIVES; BLOOD; CIRCADIAN RHYTHM; FEMALE; HUMAN; LIGHT; LIVER CIRRHOSIS; MALE; METABOLISM; MIDDLE AGED; NORMAL HUMAN; REPRODUCIBILITY; SLEEP; TIME; URINE;

ADULT; AGED; CIRCADIAN RHYTHM; FEMALE; HEALTHY VOLUNTEERS; HUMANS; LIGHT; LIVER CIRRHOSIS; MALE; MELATONIN; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SLEEP; TIME FACTORS;

EID: 84924409213     PISSN: 07420528     EISSN: 15256073     Source Type: Journal    
DOI: 10.3109/07420528.2014.961607     Document Type: Article

References (31)

1. Aldhous ME, Arendt J. (1988). Radioimmunoassay for 6-sulphatoxymelatonin in urine using an iodinated tracer. Ann Clin Biochem. 25:298-303.
2. Bland JM, Altman DG. (1986). Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1:307-10.
3. Bojkowski CJ, Arendt J, Shih MC, Markey SP. (1987). Melatonin secretion in humans assessed by measuring its metabolite, 6-sulfatoxymelatonin. Clin Chem. 33:1343-8.
4. Breslow ER, Phillips AJ, Huang JM, et al. (2013). A mathematical model of the circadian phase-shifting effects of exogenous melatonin. J Biol Rhythms. 28:79-89.
5. Brown EN, Choe Y, Shanahan TL, Czeisler CA. (1997). A mathematical model of diurnal variations and comparison to plasma melatonin levels. Am J Physiol Soc. 272:E506-16.
6. Czeisler CA, Duffy JF, Shanahan TL, et al. (1999). Stability, precision, and near-24-hour period of the human circadian pacemaker. Science. 284:2177-81.
7. Duffy JF, Dijk DJ. (2002). Getting through to circadian oscillators: Why use constant routines?. J Biol Rhythms. 17:4-13.
8. Fraser S, Cowen P, Franklin M, et al. (1983). Direct radioimmunoassay for melatonin in plasma. Clin Chem. 29:396-7.
9. Gamble KL, Berry R, Frank SJ, Young ME. (2014). Circadian clock control of endocrine factors. Nat Rev Endocrinol. 10:466-75.
10. Jakobsen J, Pedersen AN, Ovesen L. (2003). Para-aminobenzoic acid (PABA) used as a marker for completeness of 24 hour urine: Effects of age and dosage scheduling. Eur J Clin Nutr. 57: 138-42.
11. Kircheis G, Wettstein M, Timmermann L, et al. (2002). Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology. 35:357-66.
12. Lockley SW, Skene DJ, James K, et al. (2000). Melatonin administration can entrain the free-running circadian system of blind subjects. J Endocrinol. 164:R1-6.
13. MacDonald SWS, Nyberg L, Backman L. (2006). Intra-individual variability in behavior: Links to brain structure, neurotransmission and neuronal activity. Trends Neurosci. 29:474-80.
14. Magri F, Sarra S, Cinchetti W, et al. (2004). Qualitative and quantitative changes of melatonin levels in physiological and pathological aging and in centenarians. J Pineal Res. 36:256-61.
15. Mantele S, Otway DT, Middleton B, et al. (2012). Daily rhythms of plasma melatonin, but not plasma leptin or leptin mRNA, vary between lean, obese and type 2 diabetic men. Plos One. 7: e37123.
16. Maury E, Hong HK, Bass J. (2014). Circadian disruption in the pathogenesis of metabolic syndrome. Diabetes Metab. doi: 10. 1016/j. diabet. 2013. 12. 005. [Epub ahead of print].
17. Middleton B. (2006). Measurement of melatonin and 6-sulphatoxymelatonin. Methods Mol Biol. 324:235-54.
18. Minors DS, Waterhouse JM. (1988). Mathematical and statistical analysis of circadian rhythms. Psychoneuroendocrinology. 13: 443-64.
19. Montagnese S, De Pitta C, De Rui M, et al. (2014). Sleepwake abnormalities in patients with cirrhosis. Hepatology. 59: 705-12.
20. Montagnese S, Middleton B, Skene DJ, Morgan MY. (2009). Sleepwake patterns in patients with cirrhosis: All you need to know on a single sheet. A simple sleep questionnaire for clinical use. J Hepatol. 51:690-5.
21. Montagnese S, Middleton B, Mani AR, et al. (2010). On the origin and the consequences of circadian abnormalities in patients with cirrhosis. Am J Gastroenterol. 105:1773-81.
22. Paakkonen T, Makinen TM, Leppaluoto J, et al. (2006). Urinary melatonin: A noninvasive method to follow human pineal function as studied in three experimental conditions. J Pineal Res. 40:110-5.
23. Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol Int. 27:1911-29.
24. Perez-Rico C, de la Villa P, Arribas-Gomez I, Blanco R. (2010). Evaluation of functional integrity of the retinohypothalamic tract in advanced glaucoma using multifocal electroretinography and light-induced melatonin suppression. Exp Eye Res. 91: 578-83.
25. Reichenbach A, Faude F, Enzmann V, et al. (1997). The Mu ller (glial) cell in normal and diseased retina: A case for single-cell electrophysiology. Ophthalmic Res. 29:326-40.
26. St Hilaire MA, Gronfier C, Zeitzer JM, Klerman EB. (2007). A physiologically based mathematical model of melatonin including ocular light suppression and interactions with the circadian pacemaker. J Pineal Res. 43:294-304.
27. St Hilaire MA, Klerman EB, Khalsa SBS, et al. (2007). Addition of a non-photic component to a light-based mathematical model of the human circadian pacemaker. J Biol Rhythms. 247: 583-99.
28. Steindl PE, Ferenci P, Marktl W. (1997). Impaired hepatic catabolism of melatonin in cirrhosis. Ann Intern Med. 127:494.
29. Thapan K, Arendt J, Skene DJ. (2001). An action spectrum for melatonin suppression: Evidence for a novel non-rod, noncone photoreceptor system in humans. J Physiol. 535:261-7.
30. Yamazaki S, Numano R, Abe M, et al. (2000). Resetting central and peripheral circadian oscillators in transgenic rats. Science. 288: 682-5.
31. Youngstedt SD, Kripke DF, Elliott JA, Rex KM. (2005). Circadian phase-shifting effects of a laboratory environment: A clinical trial with bright and dim light. J Circadian Rhythms. 9: 3-11.